NZ230996A - Immunogenic recombinant polypeptides and their use in the production of neutralising antibodies against viral haemorrhagic septicaemia virus - Google Patents

Immunogenic recombinant polypeptides and their use in the production of neutralising antibodies against viral haemorrhagic septicaemia virus

Info

Publication number
NZ230996A
NZ230996A NZ230996A NZ23099689A NZ230996A NZ 230996 A NZ230996 A NZ 230996A NZ 230996 A NZ230996 A NZ 230996A NZ 23099689 A NZ23099689 A NZ 23099689A NZ 230996 A NZ230996 A NZ 230996A
Authority
NZ
New Zealand
Prior art keywords
production
against viral
antibodies against
recombinant polypeptides
neutralising antibodies
Prior art date
Application number
NZ230996A
Inventor
Andre Jean Joseph Renard
Michel-Ernest-Ghislain M Thiry
Original Assignee
Eurogentec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurogentec Sa filed Critical Eurogentec Sa
Publication of NZ230996A publication Critical patent/NZ230996A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/033Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the internal surface of the plasma membrane, e.g. containing a myristoylation motif
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/20011Rhabdoviridae
    • C12N2760/20022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Farming Of Fish And Shellfish (AREA)

Abstract

The invention relates to new amino acid sequences comprising particularly all or part of the amino acid chain represented in figures III and IIIcontinued. These amino acids sequences may be used as active principle of a vaccine against viral hemorragic septicemy of fish.
NZ230996A 1988-10-12 1989-10-12 Immunogenic recombinant polypeptides and their use in the production of neutralising antibodies against viral haemorrhagic septicaemia virus NZ230996A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP88402587 1988-10-12

Publications (1)

Publication Number Publication Date
NZ230996A true NZ230996A (en) 1991-09-25

Family

ID=8200430

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ230996A NZ230996A (en) 1988-10-12 1989-10-12 Immunogenic recombinant polypeptides and their use in the production of neutralising antibodies against viral haemorrhagic septicaemia virus

Country Status (11)

Country Link
EP (1) EP0377349B1 (en)
JP (1) JPH04502902A (en)
AT (1) ATE106944T1 (en)
AU (1) AU4426689A (en)
CA (1) CA2000570A1 (en)
DE (1) DE68915988T2 (en)
DK (1) DK64691A (en)
ES (1) ES2055132T3 (en)
IS (1) IS3511A7 (en)
NZ (1) NZ230996A (en)
WO (1) WO1990004028A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2196005T3 (en) * 1992-03-27 2003-12-16 Int Flower Dev Pty Ltd GENETIC SEQUENCES CODING ENZYMES OF THE FLAVONOID ROUTE WITH FLAVONOID ACTIVITY -3`-HYDROXYLASE AND ITS USES.
EP2322656A1 (en) * 2009-11-17 2011-05-18 Centre National de la Recherche Scientifique (C.N.R.S) Methods for diagnosing skin diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2492841B1 (en) * 1980-10-23 1983-07-22 Agronomique Inst Nat Rech MUTANT VIRUS OF VIRAL HEMORRHAGIC SEPTICEMIA, VACCINE CONTAINING THIS MUTANT, AND PROCESS FOR PREPARING THE SAME

Also Published As

Publication number Publication date
JPH04502902A (en) 1992-05-28
DK64691A (en) 1991-06-12
ES2055132T3 (en) 1994-08-16
EP0377349B1 (en) 1994-06-08
WO1990004028A1 (en) 1990-04-19
CA2000570A1 (en) 1990-04-12
AU4426689A (en) 1990-05-01
ATE106944T1 (en) 1994-06-15
DE68915988T2 (en) 1994-09-29
IS3511A7 (en) 1990-04-13
DE68915988D1 (en) 1994-07-14
DK64691D0 (en) 1991-04-11
EP0377349A1 (en) 1990-07-11

Similar Documents

Publication Publication Date Title
DK532184A (en) ANTIGEN AMINO ACID SEQUENCES
ATE373010T1 (en) GAG ANTIGEN AND ITS USE FOR DETECTING LAV INFECTION, AND IN IMMUNOGENIC COMPOSITIONS
IL91843A0 (en) Hiv proteins and peptides useful in the diagnosis,prophylaxis aids or therapy of aids
HU9200548D0 (en) Improved activity process of recombined proteins
EP0423224A4 (en) Leader sequence inducing a post-translational modification of polypeptides in bacteria, and gene therefor
IL90035A (en) Synthetic multimeric hepatitis b virus vaccine including both t cell and b cell determinants
GR3031889T3 (en) Lipopeptide inducing T-cytotoxic lymphocytes and their use as vaccines.
ZA886273B (en) Novel hiv proteins and peptides useful in the diagnosis,prophylaxis or therapy of aids
DK288789A (en) PEPTIDES AND ACID ADDITION SALTS THEREOF, THEIR PREPARATION AND USE
IE870507L (en) Bovine virus diarrhea and hog cholera vaccines
NZ230996A (en) Immunogenic recombinant polypeptides and their use in the production of neutralising antibodies against viral haemorrhagic septicaemia virus
EP0250000A3 (en) Polypeptides, their preparation and their use
ES2078229T3 (en) PROCEDURE FOR THE PREPARATION OF A POLYPEPTIDE SIMILAR TO MOTILINE AND ITS EXPRESSION.
DE69225473D1 (en) POLYPEPTIDES DERIVED FROM THE ENDONUCLEASE PROTEIN OF HUMAN IMMUNE WEAKNESS VIRUS
DK262986D0 (en) PEPTID MATERIAL WITH THYMUS HUMORAL ACTIVITY
EP0288198A3 (en) Production of peptide
ES2033212A6 (en) Ancrod proteins, their production and use.
NZ224251A (en) Synthetic rhinovirus (hrv) peptides and vaccines
DK257887D0 (en) PROCEDURE FOR PREPARING HBCAG IN YEARS AND PLASMID TO USE IN EXERCISE OF THE PROCEDURE
WO1992001794A3 (en) Ancrod-like proteins, their preparation and their use
DK411686A (en) PEPTIDES
DK119391A (en) HUMAN INSULIN ANALOGS
TH4070EX (en) DNA sequence containing the code of P31 seraphase antigen, modified hepatitis B virus.